What can Parkinson’s Disease Learn from the Recent Progress in Alzheimer’s Disease? Lessons for HER-096
Time: 2:30 pm
day: Blood-Based Biomarker Focus Day
Details:
- Learning from the recent Alzheimer’s Disease trial successes and how this can help inform PD treatment development, highlighting the importance of biomarkers
- Understanding the importance of surrogate markers and development of clinical endpoints for a faster read on clinical trials
- Pushing early biology and biomarker discovery to support clinical development, examples from HER-096
